National Resilience, LLC
Corporate Compliance
Last Revised on March 4, 2024
At Resilience, we are committed to upholding the highest standards of Corporate Compliance. Our dedication to integrity, ethics, and regulatory adherence is paramount. We operate with accountability, ensuring that every aspect of our business aligns with applicable laws and industry regulations. By fostering a culture of compliance, we aim to build trust among our stakeholders, safeguard our reputation, and contribute to a sustainable and responsible business environment. Explore this section to learn more about our commitment to Corporate Compliance and the principles that guide our practices.
Corporate Compliance Plan
Our Corporate Compliance Plan assists Resilience with detecting and preventing potential violations of laws, regulations, Codes of Practice, and customer obligations related to Corporate Compliance. Our Plan also supports Resilience by establishing relevant and informative Corporate Policies, Standard Operating Procedures, and Trainings related to Corporate Compliance topics.
Corporate Compliance Governance
Corporate Compliance Governance is critical to establishing an effective Corporate Compliance Program. Our governance approach aligns with the seven (7) elements of an effective Corporate Compliance Program, as described by the U.S. Office of Inspector General ("OIG"). Resilience has implemented governance capabilities, such as assigning a Corporate Compliance Officer, and an Executive Committee that meets with the Resilience Senior Leadership Team and Board of Directors (or Committees thereof) to discuss Corporate Compliance topics.
Global Code of Business Conduct and Ethics
Resilience has developed a comprehensive Global Code of Business Conduct and Ethics (the “Code”), applicable to every member of our team. It is mandatory for all directors, officers, employees, and third-party personnel (i.e., contractors, contingent workers, and consultants) to adhere to the Code, along with other pertinent policies relevant to their respective roles and activities.
SB 1765 Declaration
California law SB 1765, codified at California Business and Professions Code, Sections 119400 to 119402 (“the California law”), requires all pharmaceutical (manufacturing) and medical device companies to adopt a Corporate Compliance Plan based upon the OIG Guidance and the PhRMA Code. Under the California law, a pharmaceutical manufacturing company must also annually declare that it is in compliance with its own Corporate Compliance Plan and the requirements of the Sections 119400 to 119402. A pharmaceutical manufacturing company must make its Corporate Compliance Plan and its annual declaration of compliance available to the public on its website and through a toll-free number at 1-888-737-2460. We understand the California statute only imposes these obligations for activities directed to citizens of California.
Resilience declares that to the best of our knowledge and based on a good faith understanding of the California statute, as of January 2024, Resilience is in compliance with the Corporate Compliance Plan described above. The Corporate Compliance Plan is intended to be a dynamic program to meet the Company’s evolving compliance needs and expectations. Therefore, Resilience will continue to develop and refine its Corporate Compliance Plan.
Annual Spending Limit
The California law requires pharmaceutical manufacturing companies to adopt a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical manufacturing company and its employees and representatives may give or otherwise provide to an individual medical or healthcare professional in California. The limit does not include amounts attributable to financial support for continuing medical education or payment for legitimate professional services.
Resilience has adopted an annual spending limit of $3,000.00. This limit is neither an average spending limit, nor a targeted spending limit, and Resilience believes that its actual spending will be less than this limit. Resilience reserves the right to revise its annual limit from time to time.
Modern Slavery and Human Trafficking Statement
Last Revised on May 5, 2026
Introduction
National Resilience, LLC and its subsidiaries (collectively, “Resilience” or the “Company”) are committed to conducting business ethically and with respect for human rights. The Company does not tolerate slavery, forced labor, child labor, or human trafficking in any part of its operations or supply chain.
Although Resilience is not currently subject to any specific modern slavery reporting requirements under US law, the Company recognizes the importance of responsible supply chain practices and provides this statement to support transparency for our customers and business partners.
Our Business
Resilience is a North American contract development and manufacturing organization (CDMO) focused on delivering high-quality, scalable manufacturing solutions for advanced therapies. With capabilities spanning biologics drug substance, cell-based therapies, and aseptic drug product manufacturing for both small and large molecules, Resilience partners with leading biopharma companies to bring complex medicines to market faster and more reliably. The Company’s operations primarily consist of scientific, technical, and manufacturing services conducted in the United States and Canada.
Commitment to Ethical Business Practices
The Company maintains policies and practices intended to promote ethical conduct and compliance with applicable laws, including policies addressing:
- ethical business conduct and integrity
- compliance with applicable labor and employment laws
- non-discrimination and fair treatment of employees
- responsible sourcing and supplier expectations
These policies apply to employees and, where appropriate, to contractors and suppliers.
Supply Chain Expectations
The Company expects its suppliers, contractors, and business partners to comply with all applicable labor and employment laws and to conduct their operations in a manner that respects fundamental human rights. Suppliers are expected to comply with applicable laws, rules, regulations, codes, treaties, conventions, and other requirements prohibiting forced or indentured labor, inhumane treatment, human trafficking, and any form of child labor or exploitation of vulnerable populations within their supply chain. To help our partners understand Resilience’s values, the Company’s Third-Party Code of Conduct underscores these requirements.
Ongoing Commitment
The Company will continue to evaluate its policies and practices to support responsible sourcing and ethical business conduct throughout its operations.
Approval
This statement has been approved by the Company’s leadership and is published to provide transparency regarding the Company’s approach to ethical business practices.